Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Texting your way to better hearing: NHS tests florence system

NCT ID NCT07146607

Symptom relief Sponsor: WSAUD A/S Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if a text-messaging system called Florence can help new hearing aid users wear their devices more often. About 70 adults getting their first NHS hearing aid will either receive standard care or also get supportive texts. The goal is to see if this simple approach improves hearing aid use and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

WP1: Pilot Feasibility Study (n=60, 30 per group intervention/control (treatment as usual)) Inclusion criteria * Aged ≥18 years (no upper age limit) * Prescribed their first NHS acoustic hearing aid(s) for the primary concern of hearing loss * Able and willing to provide informed consent * Not currently participating in similar research * Access to a mobile device (This is not required to be a smart phone device) Exclusion criteria * Registered on a pre-existing Florence text-messaging protocol. * Unable to read/understand English WP2: Nested Process Evaluation (minimum n=10 patients, n=2 clinicians) Inclusion criteria (patients) * Aged ≥18 years (no upper age limit) * Prescribed their first NHS acoustic hearing aid(s) for the primary concern of hearing loss * Able and willing to provide informed consent Exclusion criteria (patients) * Registered on a pre-existing Florence text-messaging protocol. * Unable to read/understand English Inclusion criteria (clinicians) * Aged ≥18 years (no upper age limit) * Able and willing to provide informed consent Exclusion criteria (clinicians) • Not meeting criteria for inclusion

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing loss are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hearing loss

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Audiology Department Suite 2 Thomas Linacre Centre Parsons Walk Wigan WN1 1RU

    RECRUITING

    Wigan, WN1 1RU, United Kingdom

  • QMC Ropewalk House

    ENROLLING_BY_INVITATION

    Nottingham, Nottinghamshire, NG1 5DU, United Kingdom

  • Sunderland Royal Hospital, Kayll Road, Sunderland, SR4 7TP

    RECRUITING

    Sunderland, SR4 7TP, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.